Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a gentle rocking bed boost memory and sleep for brain injury patients?

NCT ID NCT07658027

Symptom relief Sponsor: Cereneo AG Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study investigates whether sleeping on a gently rocking bed can improve sleep quality and memory in people undergoing neurorehabilitation after conditions like stroke, traumatic brain injury, or inflammatory diseases of the central nervous system. Participants will sleep on the rocking bed for 14 nights and undergo sleep assessments. The goal is to see if this simple, non-invasive approach can enhance standard memory training.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
rocking bed (Somnomat)
What this could lead to
If it works, this could offer a simple, drug-free way to boost memory and sleep quality for people recovering from brain injuries or diseases.
What could go wrong
This is a small early study with only 20 participants, and the rocking bed is not yet certified in Switzerland. Benefits are not guaranteed, and there are minor risks like falling or discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Neurorehabilitation clinic patients with focus in learning or memory in neuropsychological training * Age \> 18 years * Signed informed consent * Smokers and non-smokers * Patients of all ethnical backgrounds Exclusion Criteria: * Disorders of the vestibular system or sensitivity to motion sickness (Motion Sickness Susceptibility Questionnaire \<10 (Golding, 2006) * Hygiene-relevant infections requiring sanitization of patient care equipment: active or their asymptomatic carrying (as surface material of the rocking bed is not eligible * Cognitive or motor deficit presenting a risk for self-use of the rocking bed at night: utmostly, creating the risk of falls during embarking and disembarking from the bed * Transfer deficits. \>1 persons are needed for transfer * Short planned duration of stay \<4 weeks * Pregnancy or lactation * Refusal to participate

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Memory deficit aquired due to the disease, E.G. stroke, neurodegeneration, inflammatory disease of CNS, traumatic brain injury are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Brain Injuries, Traumatic Nerve Degeneration stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Memory deficit aquired due to the disease, E.G. stroke, neurodegeneration, inflammatory disease of CNS, traumatic brain injury

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • cereneo Schweiz AG, Hertensteinstrasse 162 CH-6353

    Weggis, 6353, Switzerland